Skip to content

The MARVIN Chatbots to Provide Information for Different Health Conditions

HIV Infections | Breast Cancer | Pediatric Emergency Medicine

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    14 and up

Critères de participation

Inclusion Criteria for all objectives:

* being 14 years or older;
* being fluent in English and/or French;
* being able to understand the requirements of study participation and provide informed consent during the duration of the study;
* having access to a smartphone, tablet, or computer at home/at workplace;
* having access to an internet connection at home or data plan on their device.

Inclusion Criteria Specific to objectives 2 and 3:

* accept to use a Facebook Messenger-based Chatbot;
* accept to use or create a personal Facebook account;
* accept Facebook's privacy and data security policies.

Exclusion Criteria:

* not meeting the inclusion criteria
* any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)

Lieu de l'étude

Centre hospitalier de l'Université de Montréal (CHUM)
Centre hospitalier de l'Université de Montréal (CHUM)
Montréal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Marie-Pacale Pomey, MD, PhD

[email protected]
514 890 8000
McGill University Health Centre (MUHC)
McGill University Health Centre (MUHC)
Montréal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Bertrand Lebouché, MD, PhD

[email protected]
5148432090
Étude parrainée par
McGill University Health Centre/Research Institute of the McGill University Health Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT05789901